Pay in 4 interest-free payments of $5.89 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
10.2337/dc21-2252 123
5 This is an impressive feat given the significant reduction in force across the agency in the spring of 2025
If you are interested in DSIP, our providers can help you understand what is known, what is still uncertain, and whether peptide therapy makes sense for your situation
Breakup by Region: North America United States Canada Europe Germany France United Kingdom Italy Spain Others Asia Pacific China Japan India South Korea Australia Indonesia Others Latin America Brazil Mexico Others Middle East and Africa North America leads the market, accounting for the largest GLP-1 receptor agonist market share The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada)
